Announced
Completed
Synopsis
Leonard Green and Aurora Capital-backed Pace Analytical, a provider of a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries, completed the acquisition of New Jersey laboratory facility from Curia, a contract development and manufacturing organization. Financial terms were not disclosed. “This acquisition builds upon our leadership in the analytical services space to support emerging drug development partners through commercialization activities. I am excited to leverage this expansion with the New Jersey team to further collaborate with our pharma and biopharma clients,” Eric Roman, Pace Analytical CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.